BRPI0511206A - composição farmacêutica anidra e uso de um ungüento oleaginoso - Google Patents
composição farmacêutica anidra e uso de um ungüento oleaginosoInfo
- Publication number
- BRPI0511206A BRPI0511206A BRPI0511206-0A BRPI0511206A BRPI0511206A BR PI0511206 A BRPI0511206 A BR PI0511206A BR PI0511206 A BRPI0511206 A BR PI0511206A BR PI0511206 A BRPI0511206 A BR PI0511206A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- anhydrous pharmaceutical
- oil ointment
- anhydrous
- ointment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPOSIçãO FARMACêUTICA ANIDRA E USO DE UM UNGüENTO OLEAGINOSO A presente invenção trata de uma composição farmacêutica anidra destinada ao tratamento da psoríase caracterizada pelo lato de compreender um ungüento oleaginoso e, como princípios ativos, calcitriol e 17-propionato de clobetasol, sendo que os referidos ativos estão em forma solubilizada na referida composição.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0406609A FR2871694B1 (fr) | 2004-06-17 | 2004-06-17 | Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises |
PCT/FR2005/001493 WO2006005842A1 (fr) | 2004-06-17 | 2005-06-15 | Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises. |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0511206A true BRPI0511206A (pt) | 2007-11-27 |
Family
ID=34946515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0511206-0A BRPI0511206A (pt) | 2004-06-17 | 2005-06-15 | composição farmacêutica anidra e uso de um ungüento oleaginoso |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050281848A1 (pt) |
EP (1) | EP1758588B1 (pt) |
JP (1) | JP2008502661A (pt) |
CN (1) | CN101090725A (pt) |
AT (1) | ATE489098T1 (pt) |
AU (1) | AU2005261569A1 (pt) |
BR (1) | BRPI0511206A (pt) |
CA (1) | CA2567680A1 (pt) |
DE (1) | DE602005024959D1 (pt) |
ES (1) | ES2360469T3 (pt) |
FR (1) | FR2871694B1 (pt) |
MX (1) | MXPA06014407A (pt) |
RU (1) | RU2007101516A (pt) |
WO (1) | WO2006005842A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2885527B1 (fr) * | 2005-05-16 | 2007-06-29 | Galderma Res & Dev | Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise |
WO2008027532A2 (en) * | 2006-08-29 | 2008-03-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions including vitamin d and corticosteroid |
FR2909284B1 (fr) * | 2006-11-30 | 2012-09-21 | Galderma Sa | Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien |
FR2912655A1 (fr) * | 2007-02-15 | 2008-08-22 | Galderma Sa | Produit de soin cutane a double compartiment comprenant du calcitriol et du propionate de clobetasol, et son utilisation |
EP1970048A1 (en) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D |
US10265265B2 (en) * | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
WO2010072958A2 (fr) * | 2008-12-23 | 2010-07-01 | Galderma S.A. | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau |
NZ601001A (en) * | 2009-12-22 | 2014-07-25 | Leo Pharma As | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue |
JP5873439B2 (ja) * | 2009-12-22 | 2016-03-01 | レオ ファーマ アクティーゼルスカブ | ビタミンd類似体および溶媒と界面活性剤の混合物を含む皮膚組成物 |
ES2736256T3 (es) | 2011-03-14 | 2019-12-27 | Drug Delivery Solutions Ltd | Composición oftálmica |
CN104666312B (zh) * | 2015-02-12 | 2017-11-07 | 重庆华邦制药有限公司 | 含有卡泊三醇和二丙酸倍他米松的制剂 |
CN108969527B (zh) * | 2017-05-31 | 2021-05-11 | 上海通用药业股份有限公司 | 一种药物制剂及其制备方法和用途 |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1272953A (en) * | 1984-10-08 | 1990-08-21 | Yuji Makino | Pharmaceutical composition for external use containing active-type vitamin d.sub.3 |
US5185150A (en) * | 1990-08-24 | 1993-02-09 | Wisconsin Alumni Research Fdn. | Cosmetic compositions containing 19-nor-vitamin D compounds |
SI2915534T1 (sl) * | 1999-04-23 | 2018-10-30 | Leo Pharma A/S | Farmacevtski sestavek za dermalno uporabo za zdravljenje psoriaze, ki vsebuje vitamin D in kortikosteroid |
RU2271810C2 (ru) * | 2000-10-27 | 2006-03-20 | Лео Фарма А/С | Композиции местного применения, содержащие, по меньшей мере, один витамин d или один аналог витамина d и, по меньшей мере, один кортикостероид |
AU2003294027B2 (en) * | 2002-12-17 | 2009-09-10 | Galderma S.A. | Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate |
FR2848454B1 (fr) * | 2002-12-17 | 2007-03-30 | Galderma Res & Dev | Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide |
US7582307B2 (en) * | 2003-11-26 | 2009-09-01 | Harmony Labs, Inc. | Dermatological composition |
-
2004
- 2004-06-17 FR FR0406609A patent/FR2871694B1/fr not_active Expired - Fee Related
- 2004-10-07 US US10/959,431 patent/US20050281848A1/en not_active Abandoned
-
2005
- 2005-06-15 JP JP2007515996A patent/JP2008502661A/ja not_active Withdrawn
- 2005-06-15 BR BRPI0511206-0A patent/BRPI0511206A/pt not_active Application Discontinuation
- 2005-06-15 AT AT05777135T patent/ATE489098T1/de not_active IP Right Cessation
- 2005-06-15 WO PCT/FR2005/001493 patent/WO2006005842A1/fr active Application Filing
- 2005-06-15 ES ES05777135T patent/ES2360469T3/es active Active
- 2005-06-15 MX MXPA06014407A patent/MXPA06014407A/es not_active Application Discontinuation
- 2005-06-15 RU RU2007101516/15A patent/RU2007101516A/ru unknown
- 2005-06-15 AU AU2005261569A patent/AU2005261569A1/en not_active Abandoned
- 2005-06-15 CN CNA2005800200365A patent/CN101090725A/zh active Pending
- 2005-06-15 DE DE602005024959T patent/DE602005024959D1/de active Active
- 2005-06-15 EP EP05777135A patent/EP1758588B1/fr active Active
- 2005-06-15 CA CA002567680A patent/CA2567680A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2567680A1 (fr) | 2006-01-19 |
MXPA06014407A (es) | 2007-02-19 |
AU2005261569A1 (en) | 2006-01-19 |
ATE489098T1 (de) | 2010-12-15 |
US20050281848A1 (en) | 2005-12-22 |
CN101090725A (zh) | 2007-12-19 |
ES2360469T3 (es) | 2011-06-06 |
EP1758588A1 (fr) | 2007-03-07 |
FR2871694A1 (fr) | 2005-12-23 |
FR2871694B1 (fr) | 2008-07-04 |
EP1758588B1 (fr) | 2010-11-24 |
DE602005024959D1 (de) | 2011-01-05 |
WO2006005842A1 (fr) | 2006-01-19 |
RU2007101516A (ru) | 2008-07-27 |
JP2008502661A (ja) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0511206A (pt) | composição farmacêutica anidra e uso de um ungüento oleaginoso | |
BRPI0416752B8 (pt) | composição farmacêutica, uso de um ou mais compostos, e, compostos | |
LTC1620113I2 (lt) | Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui | |
EA200700118A1 (ru) | Амидосоединения и их применение в качестве лекарственных средств | |
WO2007011606A3 (en) | USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS | |
BR112014000178A2 (pt) | composições tópicas | |
ATE448777T1 (de) | Mittel für die transdermale verabreichung von nikotin | |
BRPI0411699A (pt) | compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos | |
BRPI0620436A8 (pt) | compostos miméticos de lisina modificados, composição farmacêutica e uso | |
ECSP055851A (es) | Derivados de indolil pirazinona utiles para el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
BRPI0512108A (pt) | antibióticos contendo complexos de ácido borìnico e métodos de uso | |
ATE249214T1 (de) | Pentafluorobenzensulfonamide und analoge | |
MY158428A (en) | Topical composition for the treatment of actinic keratosis | |
CY1114838T1 (el) | Φαρμακευτικες τοπικες συνθεσεις | |
BRPI0514723A8 (pt) | composições contendo componentes de agonista alfa-2-adrenérgico | |
ATE555656T1 (de) | Verwendung von seh-hemmern als analgetika | |
CY1109507T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια | |
UY29069A1 (es) | Uso de compuestos tpo miméticos y composiciones farmacéuticas para el tratamiento de la anemia | |
CL2011000722A1 (es) | Composicion farmaceutica en forma de unguento estable al almacenamiento, que comprende: a) un compuesto de vitamina d, b) un corticosteroide y c) un compuesto alquilamino sustituido, en un vehiculo de petrolato que opcionalmente contiene aceite mineral, tocoferol o una combinacion de ellos; uso en tratamiento de la psoriasis. | |
UY27275A1 (es) | Composiciones y metodos para aumentar la biodisponibilidad de agentes farmacéuticos | |
EA200870058A1 (ru) | Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран | |
CY1113424T1 (el) | Μεθοδος αντιμετωπισης του καρκινου ή/και παθησεις με κυτταρικη υπερπλασια και παραγοντες που στοχευουν τον αναβολισμο υαλουρονανης για τον ιδιο σκοπο | |
BR112016030507A8 (pt) | compostos relacionados à vitamina d, composição farmacêutica, e kit | |
AR023546A1 (es) | Disulfuros ciclicos de pirrolidincarbonilamina | |
WO2005065713A3 (de) | Arzneimittel zur topischen applikation bei tieren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |